Multiple sclerosis vs Lyme disease: A case presentation to a discussant and a review of the literature

A 46-year-old male engineer, married with two children, born in Israel, of Ashkenazi origin, previously healthy, was initially evaluated because of complaints of paresthesias in his hands and legs and in the right part of his face. Subsequently, there was some difficulty in speech, accompanied by blurred vision and an unsteady gait. On examination, behavioral disinhibition and euphoria were noted, accompanied by 'scanning speech' (dysarthria) and pyramidal syndrome (hypereflexia and bilateral Babinsky's signs), without apparent muscle weakness. Mild cerebellar signs were also found (dysmetria in both hands and ataxia). A CT scan of the brain was normal. The putient presented with neurologic symptoms that localized primarily to the brainstem. Paresthesias of all four extremities suggest bilateral involvement of the sensory tracks, whereas involvement of the right-sided face suggests unilateral involvement of the brainstem. The unsteady gait suggests involvement of the cerebellar tracks, although that could relate to sensory systems as well. Difficulties in speech could be either dysarthria, located in the brainstem, or aphasi. Physical examination revealed brainstem findings (scanning speech), pyramidal signs and a oerebellar syndrome. Of note is the disinhibitive and euphoric mood, indicative of higher cortical function involvement. The normal CT scan rules out bleeding. Given the normal CT scan, an MRII should be performed and, depending on the findings, a lumbar punctureo, to rule out an infectious process. MRI showed multiple periventricular hyper intense lesions in the T2-weighted imaging and ventricular enlargement. Increased quantities of IgG antibodies were found in the CSF and oligoclonal bands were found on immunoelectrophoresis. MS was diagnosed and the patient received a high i.v. dose of methyl-

[1]  T. Christensen,et al.  A single subtype of Epstein–Barr virus in members of multiple sclerosis clusters , 1998, Acta neurologica Scandinavica.

[2]  M. Kaplan,et al.  Human Herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report , 1998, Multiple sclerosis.

[3]  S. Bergström,et al.  Augmented intrathecal secretion of interferon-γ in response to Borrelia garinii in neuroborreliosis , 1998, Journal of Neuroimmunology.

[4]  L. Leocani,et al.  Neurophysiological and cognitive markers of disease evolution in multiple sclerosis , 1998, Multiple sclerosis.

[5]  A. Steere,et al.  Reversible cerebral hypoperfusion in Lyme encephalopathy , 1997, Neurology.

[6]  R. Kinkel,et al.  Management of multiple sclerosis. , 1997, The New England journal of medicine.

[7]  R Kikinis,et al.  Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis. , 1997, Archives of neurology.

[8]  C. Hughes,et al.  Interleukin-6 is expressed at high levels in the CNS in Lyme neuroborreliosis , 1997, Neurology.

[9]  K. Becker,et al.  Analysis of a sequenced cDNA library from multiple sclerosis lesions , 1997, Journal of Neuroimmunology.

[10]  E. Aberer,et al.  Why is chronic Lyme borreliosis chronic? , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  W. Lüke,et al.  Detection of CSF-specific oligoclonal antibodies to recombinant JC virus VP1 in patients with progressive multifocal leukoencephalopathy , 1997, Journal of Neuroimmunology.

[12]  A. Pennekamp,et al.  [Chronic neuroborreliosis with gait ataxia and cognitive disorders]. , 1997, Praxis.

[13]  R. Kaplan,et al.  Lyme encephalopathy: a neuropsychological perspective. , 1997, Seminars in neurology.

[14]  G. Wormser,et al.  Treatment and Prevention of Lyme Disease, with Emphasis on Antimicrobial Therapy for Neuroborreliosis and Vaccination , 1997, Seminars in neurology.

[15]  J. Benach,et al.  Mechanisms of Injury in Lyme Neuroborreliosis , 1997, Seminars in neurology.

[16]  G. Burmester,et al.  An optimized PCR leads to rapid and highly sensitive detection of Borrelia burgdorferi in patients with Lyme borreliosis , 1997, Journal of clinical microbiology.

[17]  J. Halperin Neuroborreliosis: Central Nervous System Involvement , 1997, Seminars in neurology.

[18]  L. Sigal,et al.  Immunologic Mechanisms in Lyme Neuroborreliosis: The Potential Role of Autoimmunity and Molecular Mimicry , 1997, Seminars in neurology.

[19]  T. Christensen,et al.  The implications of Epstein‐Barr virus in multiple‘ sclerosis ‐ a review , 1997, Acta neurologica Scandinavica. Supplementum.

[20]  J. Ruutiainen,et al.  The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up. , 1997, Brain : a journal of neurology.

[21]  B. Schmidt PCR in laboratory diagnosis of human Borrelia burgdorferi infections , 1997, Clinical microbiology reviews.

[22]  J. Pardo,et al.  [Diagnosis and treatment of facial palsy]. , 1997, Neurologia.

[23]  C. Martyn,et al.  Infection in childhood and neurological diseases in adult life. , 1997, British medical bulletin.

[24]  H. Kalimo,et al.  Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature. , 1996, Brain : a journal of neurology.

[25]  S. Medendorp,et al.  Low-dose oral methotrexate in chronic progressive multiple sclerosis , 1996, Neurology.

[26]  N. Schatz,et al.  Lyme neuroborreliosis masquerading as a brainstem tumor in a 15-year-old. , 1996, Pediatric neurology.

[27]  J. Ruutiainen,et al.  Language functions in incipient cognitive decline in multiple sclerosis , 1996, Journal of the Neurological Sciences.

[28]  J. Meulstee,et al.  Cytomegalovirus infection and Guillain-Barre syndrome , 1996, Neurology.

[29]  C. Schmid,et al.  Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis. , 1996, The Journal of infectious diseases.

[30]  J. Ruutiainen,et al.  Memory deficits and early cognitive deterioration in MS , 1996, Acta neurologica Scandinavica.

[31]  A. Malmborg,et al.  Concentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis , 1996, Antimicrobial agents and chemotherapy.

[32]  R. Zbinden,et al.  Value of clinical symptoms, intrathecal specific antibody production and PCR in CSF in the diagnosis of childhood Lyme neuroborreliosis. , 1996, Klinische Padiatrie.

[33]  P. Matzinger,et al.  Neonatal Tolerance Revisited: Turning on Newborn T Cells with Dendritic Cells , 1996, Science.

[34]  P. Lehmann,et al.  Induction of TH1 and TH2 Immunity in Neonatal Mice , 1996, Science.

[35]  K. Wood,et al.  New concepts in tolerance. , 1996, Clinical transplantation.

[36]  W. Tourtellotte,et al.  Herpes simplex virus in postmortem multiple sclerosis brain tissue. , 1996, Archives of neurology.

[37]  W. Tourtellotte,et al.  Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction. , 1996, Journal of neurovirology.

[38]  H. Link,et al.  Lyme Neuroborreliosis: Evidence for Persistent Up‐Regulation of Borrelia Burgdorferi‐Reactive Cells Secreting Interferon‐γ , 1995, Scandinavian journal of immunology.

[39]  J. Benach,et al.  Experimental immunization with Borrelia burgdorferi induces development of antibodies to gangliosides , 1995, Infection and immunity.

[40]  Massimo Filippi,et al.  Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis , 1995, Journal of the Neurological Sciences.

[41]  A. Pachner,et al.  Neuroborreliosis in the nonhuman primate: Borrelia burgdorferi persists in the central nervous system , 1995, Annals of neurology.

[42]  B. Jacobs,et al.  Anti‐GM1 IgG antibodies and campylobacter bacteria in Guillain‐Barré syndrome: Evidence of molecular mimicry , 1995, Annals of neurology.

[43]  P. Morlat,et al.  Manifestations neurologiques de la maladie de Lyme. propos de 25 cas , 1995 .

[44]  A Revonsuo,et al.  Attention related performance in two cognitively different subgroups of patients with multiple sclerosis. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[45]  G. Burmester,et al.  A Role for T Cells in the Pathogenesis of Treatment-Resistant Lyme Arthritis , 1995, Molecular medicine.

[46]  N. Koch-Henriksen,et al.  Increased risk of multiple sclerosis after late Epstein-Barr virus infection: a historical prospective study , 1995, Multiple sclerosis.

[47]  J. Benach,et al.  Lyme neuroborreliosis , 1995, Annals of neurology.

[48]  T. Benke,et al.  Lyme encephalopathy: long‐term neuropsychological deficits years after acute neuroborreliosis , 1995, Acta neurologica Scandinavica.

[49]  L. Magnarelli Current status of laboratory diagnosis for Lyme disease. , 1995, The American journal of medicine.

[50]  R. Kaiser Intrathecal immune response in neuroborreliosis: importance of cross-reactive antibodies. , 1995, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

[51]  Y. Lobet,et al.  Simultaneous presence of different Borrelia burgdorferi genospecies in biological fluids of Lyme disease patients , 1995, Journal of clinical microbiology.

[52]  S. Medendorp,et al.  Low‐dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis , 1995, Annals of neurology.

[53]  J. Ragnaud,et al.  [Neurologic manifestations of Lyme disease. Apropos of 25 cases]. , 1995, La Revue de medecine interne.

[54]  M. Lana-Peixoto Multiple sclerosis and positive Lyme serology. , 1994, Arquivos de neuro-psiquiatria.

[55]  M. Munch,et al.  Increased risk of multiple sclerosis after late Epstein-Barr virus infection. A historical prospective study , 1994, Journal of Neuroimmunology.

[56]  A. Revonsuo,et al.  Automatic and controlled information processing in multiple sclerosis. , 1994, Brain : a journal of neurology.

[57]  J. Koziol,et al.  Cladribine in treatment of chronic progressive multiple sclerosis , 1994, The Lancet.

[58]  R. Zbinden,et al.  Comparison of two methods for detecting intrathecal synthesis of Borrelia burgdorferi-specific antibodies and PCR for diagnosis of Lyme neuroborreliosis , 1994, Journal of clinical microbiology.

[59]  L. Lindquist,et al.  Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis , 1994, Neurology.

[60]  H. Hansen,et al.  A Putative New Retrovirus Associated with Multiple Sclerosis and the Possible Involvement of Epstein‐Barr Virus in This Disease a , 1994, Annals of the New York Academy of Sciences.

[61]  H. Pfister,et al.  Lyme borreliosis: basic science and clinical aspects , 1994, The Lancet.

[62]  Sigal Lh Persisting symptoms of Lyme disease--possible explanations and implications for treatment. , 1994 .

[63]  L. Sigal Persisting complaints attributed to chronic Lyme disease: possible mechanisms and implications for management. , 1994, The American journal of medicine.

[64]  M. Peterson,et al.  Lyme disease: an infectious and postinfectious syndrome. , 1994, The Journal of rheumatology.

[65]  R. Zbinden,et al.  [Demonstration of intrathecal antibody formation against Borrelia burgdorferi in Lyme neuroborreliosis]. , 1993, Schweizerische medizinische Wochenschrift.

[66]  Coyle Pk Neurologic complications of Lyme disease. , 1993 .

[67]  L. Krupp,et al.  Significance of reactive lyme serology in multiple sclerosis , 1993, Annals of neurology.

[68]  T. Miyatake,et al.  A bacterium lipopolysaccharide that elicits Guillain-Barre syndrome has a GM1 ganglioside-like structure , 1993, The Journal of experimental medicine.

[69]  A. Steere Lyme disease--1993. , 1993, Bulletin on the rheumatic diseases.

[70]  J. Kurtzke Epidemiologic evidence for multiple sclerosis as an infection , 1993, Clinical Microbiology Reviews.

[71]  A. Vogt,et al.  Intrathecal antibody synthesis in Lyme neuroborreliosis: use of recombinant p41 and a 14-kDa flagellin fragment in ELISA. , 1993, Journal of medical microbiology.

[72]  C. Lücking,et al.  Intrathecal synthesis of specific antibodies in neuroborreliosis comparison of different ELISA techniques and calculation methods , 1993, Journal of the Neurological Sciences.

[73]  J. Heesemann,et al.  The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain‐Barré syndrome and in other neuroimmunological disorders , 1993, Annals of neurology.

[74]  C. Lücking,et al.  Intrathecal synthesis of IgM and IgA in neurological diseases: comparison of two formulae with isoelectric focusing. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[75]  A. Steere,et al.  Reactivity of neuroborreliosis patients (Lyme disease) to cardiolipin and gangliosides , 1993, Journal of the Neurological Sciences.

[76]  D. Klein,et al.  Psychiatric manifestations of Lyme borreliosis. , 1993, The Journal of clinical psychiatry.

[77]  A. Steere,et al.  Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi , 1993, Infection and immunity.

[78]  A. Steere,et al.  The overdiagnosis of Lyme disease. , 1993, JAMA.

[79]  G. Comi,et al.  Brain magnetic resonance imaging correlates of cognitive impairment in multiple sclerosis , 1993, Journal of the Neurological Sciences.

[80]  D. Burdge,et al.  EXPERIENCE AT A REFERRAL CENTER FOR PATIENTS WITH SUSPECTED LYME DISEASE IN AN AREA OF NONENDEMICITY: FIRST 65 PATIENTS , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[81]  S. Williams,et al.  Molecular mimicry in Lyme disease: monoclonal antibody H9724 to B. burgdorferi flagellin specifically detects chaperonin-HSP60. , 1993, Biochimica et biophysica acta.

[82]  Å. Sidén,et al.  Intrathecal Synthesis of Anti‐Borrelia burgdorferi Antibodies in Neuroborreliosis: a Study with Special Emphasis on Oligoclonal IgM Antibody Bands , 1993, Scandinavian journal of immunology.

[83]  C. Martyn,et al.  Symptomatic Epstein-Barr virus infection and multiple sclerosis. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[84]  M. Karlsson,et al.  Borrelia burgdorferi‐specific intrathecal antibody production in neuroborreliosis , 1993, Neurology.

[85]  C. Bonnier,et al.  Neuroborreliosis Revealed By Epilepsy , 1993 .

[86]  L. Zöller,et al.  Western blot as a tool in the diagnosis of Lyme borreliosis , 1993, Electrophoresis.

[87]  G. Baranton,et al.  Polymerase chain reaction with the 30-kb circular plasmid of Borrelia burgdorferi B31 as a target for detection of the Lyme borreliosis agents in cerebrospinal fluid. , 1993, Research in microbiology.

[88]  P. Coyle Neurologic complications of Lyme disease. , 1993, Rheumatic diseases clinics of North America.

[89]  E. Fikrig,et al.  Serologic response to the Borrelia burgdorferi flagellin demonstrates an epitope common to a neuroblastoma cell line. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[90]  M. Weller,et al.  CSF and serum ganglioside antibody patterns in MS , 1992, Acta neurologica Scandinavica.

[91]  R. Bergamaschi,et al.  Neuropsychological assessment in MS: clinical, neurophysiological and neuroradiological relationships , 1992, Acta neurologica Scandinavica.

[92]  A. Lebech,et al.  Roxithromycin in Lyme borreliosis: discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migrans. , 1992, Acta dermato-venereologica.

[93]  A. Lebech,et al.  Detection of Borrelia burgdorferi DNA in urine samples and cerebrospinal fluid samples from patients with early and late Lyme neuroborreliosis by polymerase chain reaction , 1992, Journal of clinical microbiology.

[94]  Beck Rw Corticosteroid treatment of optic neuritis: A need to change treatment practices , 1992 .

[95]  T. Olsson,et al.  Virus-reactive and autoreactive T cells are accumulated in cerebrospinal fluid in multiple sclerosis , 1992, Journal of Neuroimmunology.

[96]  M. LeDoux,et al.  Lyme neuroborreliosis manifesting as an intracranial mass lesion. , 1992, Neurosurgery.

[97]  Rice Gp Virus-induced demyelination in man: models for multiple sclerosis. , 1992 .

[98]  Neil R. Miller,et al.  A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis , 1992 .

[99]  J. Halperin,et al.  PCR detection of Borrelia burgdorferi DNA in cerebrospinal fluid of Lyme neuroborreliosis patients , 1992, Neurology.

[100]  D. Isenberg,et al.  Autoimmunity associated with infection: leprosy, acute rheumatic fever and lyme disease , 1991, Current Biology.

[101]  R. McGhee,et al.  Magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis. , 1992, The Journal of neuropsychiatry and clinical neurosciences.

[102]  南後 健一 Ontogeny of thymic B cells in normal mice , 1992 .

[103]  R. Beck Corticosteroid treatment of optic neuritis: a need to change treatment practices. The Optic Neuritis Study Group. , 1992, Neurology.

[104]  R. Lange,et al.  Sequence homology between spirochaete flagellin and human myelin basic protein. , 1992, Immunology today.

[105]  G. Peltz,et al.  Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis , 1991, The Journal of experimental medicine.

[106]  Jean Côté,et al.  Lyme Disease , 1991, International journal of dermatology.

[107]  S. Ikehara,et al.  Distinct mechanisms of neonatal tolerance induced by dendritic cells and thymic B cells , 1991, The Journal of experimental medicine.

[108]  T. A. S. Group The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis , 1991, The Lancet.

[109]  A. Lebech,et al.  LYME NEUROBORRELIOSIS: A NEW SENSITIVE DIAGNOSTIC ASSAY FOR INTRATHECAL SYNTHESIS OF BORRELIA BURGDORFERI—SPECIFIC IMMUNOGLOBULIN G, A, AND M , 1992 .

[110]  L. Sigal Molecular mimicry and Lyme borreliosis , 1990, Annals of neurology.

[111]  H. Rasmussen,et al.  Antibody reactivity against animal retroviruses in multiple sclerosis , 1990, Acta neurologica Scandinavica.

[112]  M. Brainin,et al.  [Recurrent and relapsing course of borreliosis of the nervous system]. , 1990, Wiener klinische Wochenschrift.

[113]  A. Pachner Neurological manifestations of Lyme disease. , 1990, New Jersey medicine : the journal of the Medical Society of New Jersey.

[114]  H. Pfister,et al.  Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis. A prospective randomized study. , 1989, Archives of neurology.

[115]  P. Gorelick Clues to the mystery of multiple sclerosis. , 1989, Postgraduate medicine.

[116]  R. Martin,et al.  Autoimmunity in Lyme disease: molecular cloning of antigens recognized by antibodies in the cerebrospinal fluid. , 1989, Autoimmunity.

[117]  A. Pachner Borrelia burgdorferi in the Nervous System: The New “Great Imitator” , 1988, Annals of the New York Academy of Sciences.

[118]  M. Nuwer,et al.  Clinical experience with azathioprine: The pros , 1988, Neurology.

[119]  P. Rudge Cyclosporine and multiple sclerosis: The cons , 1988, Neurology.

[120]  D. Dommasch Comparative clinical trial of cyclosporine in multiple sclerosis: The pros , 1988, Neurology.

[121]  P. Francioli,et al.  Guillain-Barré syndrome following Campylobacter jejuni enteritis. Report of three cases and review of the literature. , 1988, Archives of internal medicine.

[122]  L. Kotilinek,et al.  Search for autonomously proliferating spinal fluid lymphocytes in patients with multiple sclerosis , 1988, Neurology.

[123]  W Fierz,et al.  Cyclosporine versus azathioprine in the long‐term treatment of multiple sclerosis—results of the german multicenter study , 1988, Annals of neurology.

[124]  D. Spencer,et al.  Corpus callosotomy for epilepsy. , 1988, Neurology.

[125]  K Rammohan,et al.  Magnetic resonance imaging correlates of dementia in multiple sclerosis. , 1987, Archives of neurology.

[126]  V. Dubowitz,et al.  DERMATOMYOSITIS, POLYMYOSITIS, AND COXSACKIE-B-VIRUS INFECTION , 1987, The Lancet.

[127]  N. Bowles,et al.  Coxsackie B myocarditis. , 1987, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[128]  V. Dubowitz,et al.  The role of Coxsackie B viruses in the pathogenesis of myocarditis, dilated cardiomyopathy and inflammatory muscle disease. , 1987, Biochemical Society symposium.

[129]  A. Steere,et al.  Proliferative responses of mononuclear cells in Lyme disease. Reactivity to Borrelia burgdorferi antigens is greater in joint fluid than in blood. , 1986, Arthritis and rheumatism.

[130]  H. Pfister,et al.  Intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis (Bannwarth's syndrome). , 1986, The Journal of infectious diseases.

[131]  R. Sayetta Theories of the etiology of multiple sclerosis: a critical review. , 1986, Journal of clinical & laboratory immunology.

[132]  D. McFarlin,et al.  Viral antibodies in twins with multiple sclerosis , 1985, Neurology.

[133]  R. Roos Viruses and DemyeSinating Disease of the Centra! Nervous System , 1983, Neurologic Clinics.

[134]  JOHN R. Martin,et al.  HERPES SIMPLEX VIRUS TYPES 1 AND 2 AND MULTIPLE SCLEROSIS , 1981, The Lancet.

[135]  S. Cook,et al.  Multiple sclerosis and viruses , 1980, Neurology.

[136]  G. Johnson,et al.  ATROPHIC GASTRITIS AND DERMATITIS HERPETIFORMIS , 1974 .

[137]  F. Oechsli Letter: Oral contraception and sex ratio at birth. , 1974, Lancet.